Skip to main content

Table 1 Reporting by Member States on the existence of a written national viral hepatitis strategy or plan

From: Strengthening hepatitis B and C surveillance in Europe: results from the two global hepatitis policy surveys (2013 and 2014)

  World Health Organization European sub-region Total
  West Centre East
  N = 18 (%) N = 13 (%) N = 13 (%) N = 44 (%)
Existence of a written national strategy or plan that focuses exclusively or primarily on the prevention and control of viral hepatitis:
 yes 5 (27.8) 3 (23.1) 5 (38.5) 13 (29.6)
 no 13 (78.2) 10 (76.9) 8 (61.5) 31 (70.5)
If there is a strategy or plan, does it include a surveillance component?
  N = 5 (%) N = 3 (%) N = 5 (%) N = 13 (%)
 yes 5 (100) 3 (100) 4 (80.0) 12 (92.3)
 no 0 (0) 0 (0) 1 (20.0) 1 (7.7)
If there is a strategy or plan, is it exclusive for viral hepatitis or does it also address other diseases?
  N = 5 (%) N = 3 (%) N = 5 (%) N = 13 (%)
 exclusive for viral hepatitis 1 (20.0) 1 (33.3) 2 (40.0) 4 (30.8)
 only for HBV 0 (0) 1 (33.3) 0 (0) 1 (7.7)
 only for HCV 1 (20.0) 0 (0) 0 (0) 1 (7.7)
 integrated with other diseases 3 (60.0) 1 (33.3) 3 (60.0) 7 (53.8)